Total Payments
$5,507
2024 Payments
$323.68
Companies
26
Transactions
380
Medicare Patients
330
Medicare Billing
$16,657
Payment Breakdown by Category
Food & Beverage$5,448 (98.9%)
Education$58.32 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,448 | 377 | 98.9% |
| Education | $58.32 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,564 | 139 | $0 (2024) |
| Janssen Biotech, Inc. | $794.92 | 55 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $559.21 | 42 | $0 (2024) |
| Gilead Sciences, Inc. | $514.40 | 39 | $0 (2024) |
| Echosens North America, Inc. | $368.38 | 2 | $0 (2017) |
| Covidien LP | $218.66 | 2 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $215.65 | 20 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $193.33 | 15 | $0 (2021) |
| PFIZER INC. | $155.20 | 9 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $151.79 | 11 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $323.68 | 18 | ABBVIE INC. ($159.38) |
| 2023 | $86.34 | 5 | Gilead Sciences, Inc. ($22.58) |
| 2022 | $111.73 | 5 | Janssen Biotech, Inc. ($46.95) |
| 2021 | $492.70 | 36 | AbbVie Inc. ($332.58) |
| 2020 | $579.53 | 39 | AbbVie Inc. ($251.79) |
| 2019 | $948.36 | 71 | AbbVie, Inc. ($323.37) |
| 2018 | $1,628 | 123 | AbbVie, Inc. ($319.47) |
| 2017 | $1,337 | 83 | Echosens North America, Inc. ($368.38) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: VIROLOGY | ||||||
| 09/23/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: GI | ||||||
| 08/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Immunology | ||||||
| 04/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Gastroenterology | ||||||
| 02/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: VIROLOGY | ||||||
| 02/02/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.21 | General |
| 01/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Gastroenterology | ||||||
| 12/14/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.58 | General |
| 04/14/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $19.17 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/28/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: GI | ||||||
| 02/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: IMMUNOLOGY | ||||||
| 05/25/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $46.95 | General |
| Category: Immunology | ||||||
| 04/21/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 17 | $2,363 | $1,022 |
| 2022 | 5 | 151 | 167 | $23,560 | $7,356 |
| 2021 | 4 | 126 | 143 | $17,166 | $6,526 |
| 2020 | 3 | 40 | 43 | $5,252 | $1,754 |
Total Patients
330
Total Services
370
Medicare Billing
$16,657
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 17 | $2,363 | $1,022 | 43.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 91 | 94 | $3,572 | $2,009 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 21 | $4,305 | $1,821 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 21 | $2,919 | $1,291 | 44.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $6,944 | $1,204 | 17.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $5,820 | $1,031 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 27 | $5,535 | $2,375 | 42.9% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 73 | 79 | $3,002 | $1,630 | 54.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 23 | $3,197 | $1,471 | 46.0% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 14 | 14 | $5,432 | $1,050 | 19.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,584 | $633.71 | 40.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 17 | $2,363 | $602.60 | 25.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 13 | 15 | $1,305 | $518.10 | 39.7% |
About Dr. Francis Dufrayne, MD
Dr. Francis Dufrayne, MD is a Specialist healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144314014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francis Dufrayne, MD has received a total of $5,507 in payments from pharmaceutical and medical device companies, with $323.68 received in 2024. These payments were reported across 380 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,448).
As a Medicare-enrolled provider, Dufrayne has provided services to 330 Medicare beneficiaries, totaling 370 services with total Medicare billing of $16,657. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Owensboro, KY
- Active Since 10/03/2006
- Last Updated 04/27/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1144314014
Products in Payments
- STELARA (Biological) $794.92
- XIFAXAN (Drug) $407.99
- Humira (Biological) $403.97
- Fibroscan (Device) $368.38
- CREON (Drug) $267.58
- HUMIRA (Biological) $236.71
- Trulance (Drug) $215.65
- LINZESS (Drug) $185.62
- Creon (Drug) $179.33
- Mavyret (Drug) $152.67
- Beacon (Device) $141.00
- XELJANZ (Drug) $133.01
- APRISO (Drug) $128.82
- Cimzia (Drug) $122.83
- Linzess (Drug) $109.37
- MAVYRET (Drug) $107.88
- DIFICID (Drug) $104.87
- Barrx (Device) $77.66
- XIFIXAN (Drug) $76.55
- ENTYVIO (Biological) $69.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Owensboro
Frank Yuk, Md, MD
Specialist — Payments: $12,325
Specialist $12,325
James Thomas, Md, MD
Specialist — Payments: $9,043
Specialist $9,043
Mr. Neil Troffkin, Md, MD
Specialist — Payments: $1,184
Specialist $1,184
David Weaver, M.d, M.D
Specialist — Payments: $440.29
Specialist $440.29
Dr. George Gilliam, M.d, M.D
Specialist — Payments: $369.50
Specialist $369.50
Mr. Harold Cannon, Md, MD
Specialist — Payments: $37.94
Specialist $37.94